ES2056981T3 - Composiciones dotadas de una capacidad de penetracion mejorada. - Google Patents

Composiciones dotadas de una capacidad de penetracion mejorada.

Info

Publication number
ES2056981T3
ES2056981T3 ES89104017T ES89104017T ES2056981T3 ES 2056981 T3 ES2056981 T3 ES 2056981T3 ES 89104017 T ES89104017 T ES 89104017T ES 89104017 T ES89104017 T ES 89104017T ES 2056981 T3 ES2056981 T3 ES 2056981T3
Authority
ES
Spain
Prior art keywords
compositions
penetration capacity
improved penetration
improved
penetration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89104017T
Other languages
English (en)
Inventor
Majid Mahjour
Bernadette Mauser
Zahra A Rashidbaigi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32512850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2056981(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Priority claimed from ZA91624A external-priority patent/ZA91624B/xx
Application granted granted Critical
Publication of ES2056981T3 publication Critical patent/ES2056981T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physical Water Treatments (AREA)
  • Laminated Bodies (AREA)

Abstract

LA PENETRACION DE VARIAS DROGAS A TRAVES DE MEMBRANAS VIVAS SE MEJORA MEDIANTE SU USO EN COMPOSICIONES TRANSDERMICAS CONTENIENDO CIERTOS SISTEMAS DE PENETRACION ELEVADA.
ES89104017T 1988-03-08 1989-03-07 Composiciones dotadas de una capacidad de penetracion mejorada. Expired - Lifetime ES2056981T3 (es)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US16532288A 1988-03-08 1988-03-08
ZA91624A ZA91624B (en) 1991-01-28 1991-01-28 Delivery device for compositions with enhanced penetration and process for preparing same
NZ236921A NZ236921A (en) 1988-03-08 1991-01-28 Laminate for transmembranal administration of a drug
AU70061/91A AU634015B2 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
IE30591A IE64308B1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
CA002035143A CA2035143A1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
FI910455A FI910455A7 (fi) 1988-03-08 1991-01-30 Parannetun läpäisevyyden omaava koostumus
KR1019910001750A KR100191456B1 (ko) 1988-03-08 1991-02-01 침투력이 향상된 조성물
NO91910403A NO910403L (no) 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat.
JP3038921A JPH04338325A (ja) 1988-03-08 1991-02-12 増強された浸透性を有する組成物
PT96779A PT96779B (pt) 1988-03-08 1991-02-15 Laminado composito de duas camadas
EP91102354A EP0499662B1 (en) 1988-03-08 1991-02-19 Compositions with enhanced penetration

Publications (1)

Publication Number Publication Date
ES2056981T3 true ES2056981T3 (es) 1994-10-16

Family

ID=32512850

Family Applications (2)

Application Number Title Priority Date Filing Date
ES89104017T Expired - Lifetime ES2056981T3 (es) 1988-03-08 1989-03-07 Composiciones dotadas de una capacidad de penetracion mejorada.
ES91102354T Expired - Lifetime ES2064780T3 (es) 1988-03-08 1991-02-19 Composiciones con penetracion mejorada.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES91102354T Expired - Lifetime ES2064780T3 (es) 1988-03-08 1991-02-19 Composiciones con penetracion mejorada.

Country Status (16)

Country Link
EP (2) EP0332147B1 (es)
JP (2) JP2939264B2 (es)
KR (1) KR100191456B1 (es)
AT (2) ATE90571T1 (es)
AU (2) AU611771B2 (es)
CA (1) CA2035143A1 (es)
DE (2) DE68907081T2 (es)
DK (2) DK175621B1 (es)
ES (2) ES2056981T3 (es)
FI (1) FI910455A7 (es)
GR (1) GR3014988T3 (es)
IE (2) IE62871B1 (es)
NO (1) NO910403L (es)
NZ (2) NZ228094A (es)
PH (1) PH26548A (es)
PT (1) PT96779B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
DE4334919A1 (de) * 1993-10-13 1995-04-20 Liedtke Pharmed Gmbh Grenzwertig wirksame Arzneiformen mit Betablockern
CA2203566C (en) * 1994-10-24 2001-10-23 Yuko Hosokawa Percutaneously administration preparation
DE19533089C1 (de) * 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6998138B2 (en) 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6916487B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6916486B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
US6646379B1 (en) 1998-12-25 2003-11-11 Matsushita Electric Industrial Co., Ltd. Metal vapor discharge lamp having cermet lead-in with improved luminous efficiency and flux rise time
EA004050B1 (ru) * 1998-12-11 2003-12-25 Бакулиш Мафатлал Хамар Способ изготовления состава местных бета-блокаторов улучшенного действия
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
DK2450041T3 (en) 2005-10-12 2018-11-19 Unimed Pharmaceuticals Llc Enhanced testosterone gel for use in the treatment of hypogonadism
JP5052558B2 (ja) * 2009-04-03 2012-10-17 ロート製薬株式会社 ゲル軟膏

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179271A (fr) * 1981-10-23 1984-12-11 Jean-Francois Grollier Composition epaissie anhydre, stable a l'oxydation, a base d'anthraline ou de l'un de ses derives dans un support constitue d'un alkyl ester d'acide gras et d'un agent epaississant, et son utilisation dans le traitement des maladies de la peau
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
ATE77962T1 (de) * 1985-02-25 1992-07-15 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration

Also Published As

Publication number Publication date
IE62871B1 (en) 1995-03-08
NO910403D0 (no) 1991-02-01
NZ228094A (en) 1991-09-25
DE69105480D1 (de) 1995-01-12
DK109689A (da) 1989-09-09
KR100191456B1 (ko) 1999-06-15
FI910455L (fi) 1992-07-31
NZ236921A (en) 1993-08-26
ATE114481T1 (de) 1994-12-15
DK0499662T3 (da) 1995-05-15
GR3014988T3 (en) 1995-05-31
ATE90571T1 (de) 1993-07-15
ES2064780T3 (es) 1995-02-01
JPH01272519A (ja) 1989-10-31
DE68907081D1 (de) 1993-07-22
PT96779B (pt) 1998-09-30
EP0332147B1 (en) 1993-06-16
DE68907081T2 (de) 1993-10-21
CA2035143A1 (en) 1992-07-30
IE910305A1 (en) 1992-07-29
PH26548A (en) 1992-08-19
AU611771B2 (en) 1991-06-20
EP0499662B1 (en) 1994-11-30
EP0332147A2 (en) 1989-09-13
DK175621B1 (da) 2004-12-27
AU7006191A (en) 1992-08-20
FI910455A7 (fi) 1992-07-31
IE890390L (en) 1989-09-08
KR920016085A (ko) 1992-09-24
AU3025889A (en) 1989-09-14
DE69105480T2 (de) 1995-04-06
PT96779A (pt) 1992-08-31
IE64308B1 (en) 1995-07-26
EP0499662A1 (en) 1992-08-26
EP0332147A3 (en) 1990-09-19
JP2939264B2 (ja) 1999-08-25
FI910455A0 (fi) 1991-01-30
NO910403L (no) 1992-08-03
AU634015B2 (en) 1993-02-11
JPH04338325A (ja) 1992-11-25
DK109689D0 (da) 1989-03-07

Similar Documents

Publication Publication Date Title
ES2056981T3 (es) Composiciones dotadas de una capacidad de penetracion mejorada.
ES2172655T3 (es) Formas galenicas estables al almacenamiento.
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
NO851170L (no) Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer
EG18379A (en) Novel pharmacological compounds
NO905632D0 (no) Opak, orientert polymer filmstruktur og fremgangsmaate forfremstilling derav.
ES2044955T3 (es) Adhesivo medico moldeable.
ES2042700T3 (es) Composiciones farmaceuticas con liberacion controlada, y metodo para su preparacion.
DE68925432D1 (de) Blutdruckumwandler im Kapselgehäuse
IT1188212B (it) Sistema per il rilascio a velocita' controllata di sostanze attive
BE879252A (fr) Masse faconnee resorbable dans le corps et a base de collagene, ainsi que son utilisation en medecine
IT1236688B (it) Procedimento e dispositivo per la creazione di una miscela combustibile-aria comburente da addurre a una combustione.
DE68915715D1 (de) Membran-Blutoxygenator.
IT1230047B (it) Protesi vascolare contenente nella parete microcapsule inglobanti cellule produttrici di ormoni.
AU6871587A (en) Verapamil dosage form
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
AU2885589A (en) Composition of anticoagulants
ES516375A0 (es) Procedimiento para la obtencion de una composicion a base de estireno para revestir alimentos y medicamentos.
EP0642346A4 (en) SOLID, STORAGE STABLE, Bacterial-killing PRE-IODINE COMPOSITION.
AU3204489A (en) A synthetic antigen evoking anti-hiv response
DE3575072D1 (de) Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2.
UA6028A1 (uk) Спосіб одержання біологічно активної композиції
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
NO891718L (no) Ekspresjon av humant interleukin-2 i metylotrofe gjaersorter.
ES2082852T3 (es) Composicion liquida de prostaglandina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 332147

Country of ref document: ES